Clinical bottom line
Robotic-assisted rehabilitation is an evolving adjunct in the management of spinal cord injury (SCI), particularly for improving upper limb function in cervical SCI patients and locomotion in lower-level injuries. Current evidence supports that robotic therapy can enhance motor recovery, increase therapy intensity, and improve patient engagement compared to conventional rehabilitation alone. However, variability in patient characteristics, robotic systems, and protocols limits definitive conclusions. Integration of robotic devices into multidisciplinary rehabilitation programs offers promising functional gains but requires individualized application and further validation (Morone et al., 2021; Yozbatiran et al., 2019).
What the evidence shows
Morone et al. (2021) provide a comprehensive review of upper limb robotic rehabilitation in cervical SCI, highlighting that robotic devices facilitate repetitive, task-specific training that promotes neuroplasticity. Studies demonstrate improvements in motor scores, dexterity, and activities of daily living, although effect sizes vary. The review underscores the importance of combining robotic therapy with conventional approaches for optimal outcomes.
Yozbatiran et al. (2019) discuss robot-assisted therapy targeting upper limb function post-cervical SCI, emphasizing enhanced motor recovery and functional independence. They note that robotic systems enable precise movement guidance and objective performance metrics, aiding tailored rehabilitation.
Van Hedel et al. (2010) review locomotor rehabilitation after SCI, including robotic gait training devices such as exoskeletons and treadmill-based systems. Evidence suggests these technologies improve walking speed, endurance, and cardiovascular fitness, especially when initiated early and combined with conventional therapy.
Ogaki et al. (2026) focus on emerging cell-based therapies for SCI, which may synergize with robotic rehabilitation by promoting neural repair and functional recovery in the future, although clinical translation remains in early stages.
Caveats and uncertainty
Heterogeneity in SCI severity, timing of intervention, and patient comorbidities complicate generalizability of robotic rehabilitation outcomes.
Robotic devices differ widely in design, control strategies, and targeted functions, making cross-study comparisons challenging.
Most studies have small sample sizes and short follow-up durations, limiting assessment of long-term benefits.
Cost, accessibility, and required technical expertise may restrict widespread implementation.
Optimal dosing, intensity, and combination with other therapies remain to be standardized.
How this may change practice
Clinicians should consider robotic-assisted rehabilitation as a complementary tool to enhance intensity and specificity of motor training in SCI patients, particularly for upper limb and gait recovery.
Early integration during inpatient and outpatient rehabilitation may maximize neuroplasticity and functional gains.
Multidisciplinary teams should tailor robotic interventions based on individual patient goals, injury characteristics, and available technology.
Objective performance data from robotic systems can inform progress monitoring and therapy adjustments.
Ongoing research and technology improvements will likely expand indications and accessibility.
Collaboration with rehabilitation engineers and therapists is essential to optimize device use and patient outcomes.